Copyright Reports & Markets. All rights reserved.

Global Recombinant DNA Technology Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Recombinant DNA Technology Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Therapeutic Agent
    • 1.4.3 Vaccine
    • 1.4.4 Biotech Crops
    • 1.4.5 Specialty Chemicals
  • 1.5 Market by Application
    • 1.5.1 Global Recombinant DNA Technology Market Share by Application: 2020 VS 2026
    • 1.5.2 Biotechnology and Pharmaceutical Companies
    • 1.5.3 Academic & Government Research Institutes
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Recombinant DNA Technology Market Perspective (2015-2026)
  • 2.2 Global Recombinant DNA Technology Growth Trends by Regions
    • 2.2.1 Recombinant DNA Technology Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Recombinant DNA Technology Historic Market Share by Regions (2015-2020)
    • 2.2.3 Recombinant DNA Technology Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Recombinant DNA Technology Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Recombinant DNA Technology Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Recombinant DNA Technology Players by Market Size
    • 3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2015-2020)
    • 3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Recombinant DNA Technology Market Concentration Ratio
    • 3.2.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2019
  • 3.3 Recombinant DNA Technology Key Players Head office and Area Served
  • 3.4 Key Players Recombinant DNA Technology Product Solution and Service
  • 3.5 Date of Enter into Recombinant DNA Technology Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Recombinant DNA Technology Historic Market Size by Type (2015-2020)
  • 4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Recombinant DNA Technology Market Size by Application (2015-2020)
  • 5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Recombinant DNA Technology Market Size (2015-2020)
  • 6.2 Recombinant DNA Technology Key Players in North America (2019-2020)
  • 6.3 North America Recombinant DNA Technology Market Size by Type (2015-2020)
  • 6.4 North America Recombinant DNA Technology Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Recombinant DNA Technology Market Size (2015-2020)
  • 7.2 Recombinant DNA Technology Key Players in Europe (2019-2020)
  • 7.3 Europe Recombinant DNA Technology Market Size by Type (2015-2020)
  • 7.4 Europe Recombinant DNA Technology Market Size by Application (2015-2020)

8 China

  • 8.1 China Recombinant DNA Technology Market Size (2015-2020)
  • 8.2 Recombinant DNA Technology Key Players in China (2019-2020)
  • 8.3 China Recombinant DNA Technology Market Size by Type (2015-2020)
  • 8.4 China Recombinant DNA Technology Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Recombinant DNA Technology Market Size (2015-2020)
  • 9.2 Recombinant DNA Technology Key Players in Japan (2019-2020)
  • 9.3 Japan Recombinant DNA Technology Market Size by Type (2015-2020)
  • 9.4 Japan Recombinant DNA Technology Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Recombinant DNA Technology Market Size (2015-2020)
  • 10.2 Recombinant DNA Technology Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Recombinant DNA Technology Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Recombinant DNA Technology Market Size by Application (2015-2020)

11 India

  • 11.1 India Recombinant DNA Technology Market Size (2015-2020)
  • 11.2 Recombinant DNA Technology Key Players in India (2019-2020)
  • 11.3 India Recombinant DNA Technology Market Size by Type (2015-2020)
  • 11.4 India Recombinant DNA Technology Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Recombinant DNA Technology Market Size (2015-2020)
  • 12.2 Recombinant DNA Technology Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Recombinant DNA Technology Market Size by Type (2015-2020)
  • 12.4 Central & South America Recombinant DNA Technology Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Monsanto Company
    • 13.1.1 Monsanto Company Company Details
    • 13.1.2 Monsanto Company Business Overview
    • 13.1.3 Monsanto Company Recombinant DNA Technology Introduction
    • 13.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2015-2020))
    • 13.1.5 Monsanto Company Recent Development
  • 13.2 Roche
    • 13.2.1 Roche Company Details
    • 13.2.2 Roche Business Overview
    • 13.2.3 Roche Recombinant DNA Technology Introduction
    • 13.2.4 Roche Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.2.5 Roche Recent Development
  • 13.3 Biogen
    • 13.3.1 Biogen Company Details
    • 13.3.2 Biogen Business Overview
    • 13.3.3 Biogen Recombinant DNA Technology Introduction
    • 13.3.4 Biogen Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.3.5 Biogen Recent Development
  • 13.4 Amgen
    • 13.4.1 Amgen Company Details
    • 13.4.2 Amgen Business Overview
    • 13.4.3 Amgen Recombinant DNA Technology Introduction
    • 13.4.4 Amgen Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.4.5 Amgen Recent Development
  • 13.5 Novartis
    • 13.5.1 Novartis Company Details
    • 13.5.2 Novartis Business Overview
    • 13.5.3 Novartis Recombinant DNA Technology Introduction
    • 13.5.4 Novartis Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.5.5 Novartis Recent Development
  • 13.6 Eli Lilly and Company
    • 13.6.1 Eli Lilly and Company Company Details
    • 13.6.2 Eli Lilly and Company Business Overview
    • 13.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
    • 13.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.6.5 Eli Lilly and Company Recent Development
  • 13.7 GenScript
    • 13.7.1 GenScript Company Details
    • 13.7.2 GenScript Business Overview
    • 13.7.3 GenScript Recombinant DNA Technology Introduction
    • 13.7.4 GenScript Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.7.5 GenScript Recent Development
  • 13.8 Pfizer Inc.
    • 13.8.1 Pfizer Inc. Company Details
    • 13.8.2 Pfizer Inc. Business Overview
    • 13.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
    • 13.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.8.5 Pfizer Inc. Recent Development
  • 13.9 Novo Nordisk
    • 13.9.1 Novo Nordisk Company Details
    • 13.9.2 Novo Nordisk Business Overview
    • 13.9.3 Novo Nordisk Recombinant DNA Technology Introduction
    • 13.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.9.5 Novo Nordisk Recent Development
  • 13.10 Sanofi
    • 13.10.1 Sanofi Company Details
    • 13.10.2 Sanofi Business Overview
    • 13.10.3 Sanofi Recombinant DNA Technology Introduction
    • 13.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2015-2020)
    • 13.10.5 Sanofi Recent Development
  • 13.11 Merck KGaA
    • 10.11.1 Merck KGaA Company Details
    • 10.11.2 Merck KGaA Business Overview
    • 10.11.3 Merck KGaA Recombinant DNA Technology Introduction
    • 10.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2015-2020)
    • 10.11.5 Merck KGaA Recent Development
  • 13.12 Profacgen
    • 10.12.1 Profacgen Company Details
    • 10.12.2 Profacgen Business Overview
    • 10.12.3 Profacgen Recombinant DNA Technology Introduction
    • 10.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2015-2020)
    • 10.12.5 Profacgen Recent Development
  • 13.13 Biocon
    • 10.13.1 Biocon Company Details
    • 10.13.2 Biocon Business Overview
    • 10.13.3 Biocon Recombinant DNA Technology Introduction
    • 10.13.4 Biocon Revenue in Recombinant DNA Technology Business (2015-2020)
    • 10.13.5 Biocon Recent Development
  • 13.14 GlaxoSmithKline
    • 10.14.1 GlaxoSmithKline Company Details
    • 10.14.2 GlaxoSmithKline Business Overview
    • 10.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
    • 10.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2015-2020)
    • 10.14.5 GlaxoSmithKline Recent Development
  • 13.15 Cibus
    • 10.15.1 Cibus Company Details
    • 10.15.2 Cibus Business Overview
    • 10.15.3 Cibus Recombinant DNA Technology Introduction
    • 10.15.4 Cibus Revenue in Recombinant DNA Technology Business (2015-2020)
    • 10.15.5 Cibus Recent Development
  • 13.16 Horizon Discovery Group
    • 10.16.1 Horizon Discovery Group Company Details
    • 10.16.2 Horizon Discovery Group Business Overview
    • 10.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
    • 10.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2015-2020)
    • 10.16.5 Horizon Discovery Group Recent Development
  • 13.17 New England Biolabs
    • 10.17.1 New England Biolabs Company Details
    • 10.17.2 New England Biolabs Business Overview
    • 10.17.3 New England Biolabs Recombinant DNA Technology Introduction
    • 10.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2015-2020)
    • 10.17.5 New England Biolabs Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Recombinant DNA Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant DNA Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Monsanto Company
    Roche
    Biogen
    Amgen
    Novartis
    Eli Lilly and Company
    GenScript
    Pfizer Inc.
    Novo Nordisk
    Sanofi
    Merck KGaA
    Profacgen
    Biocon
    GlaxoSmithKline
    Cibus
    Horizon Discovery Group
    New England Biolabs

    Market segment by Type, the product can be split into
    Therapeutic Agent
    Vaccine
    Biotech Crops
    Specialty Chemicals
    Market segment by Application, split into
    Biotechnology and Pharmaceutical Companies
    Academic & Government Research Institutes
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now